Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: a multicentre observational study.

ABSTRACT:

Background

Optimal prophylactic and therapeutic management of thromboembolic disease in patients with COVID-19 remains a major challenge for clinicians. The aim of this study was to define the incidence of thrombotic and haemorrhagic complications in critically ill patients with COVID-19. In addition, we sought to characterise coagulation profiles using thromboelastography and explore possible biological differences between patients with and without thrombotic complications.

Methods

We conducted a multicentre retrospective observational study evaluating all the COVID-19 patients received in four intensive care units (ICUs) of four tertiary hospitals in the UK between March 15, 2020, and May 05, 2020. Clinical characteristics, laboratory data, thromboelastography profiles and

SUBMITTER: Shah A 

PROVIDER: S-EPMC7499016 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature